DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,230 Cr | ₹1,388 Cr | ₹1,831 Cr | ₹1,665 Cr | ₹1,367 Cr |
What is the latest Total Non-Current Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹2,230 Cr |
| Mar2024 | ₹1,388 Cr |
| Mar2023 | ₹1,831 Cr |
| Mar2022 | ₹1,665 Cr |
| Mar2021 | ₹1,367 Cr |
How is Total Non-Current Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,230 Cr | 60.62 | |
| Mar2024 | ₹1,388 Cr | -24.19 | |
| Mar2023 | ₹1,831 Cr | 9.96 | |
| Mar2022 | ₹1,665 Cr | 21.86 | |
| Mar2021 | ₹1,367 Cr | - | |
Compare Total Non-Current Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹3,033.3 Cr | 3% | 0.4% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 3% |
0.4% |
-22.8% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses